6076 - 6100 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Neuropsychiatric symptoms in untreated Parkinson’s diseaseJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 13Issue #:Start Page: 815End Page: 826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s130997Best OA location URL: https://www.dovepress.com/getfile.php?fileID=35506Citation Count: 41
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia2017OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 36
- Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers2017OPENTitle: Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 133Issue #: 5Start Page: 839End Page: 856Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-017-1685-yBest OA location URL: https://europepmc.org/articles/pmc5613285?pdf=renderCitation Count: 206
-
OPENTitle: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 5Start Page: 2627End Page: 2634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23547Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23547Citation Count: 49
- Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials2017RESTRICTEDTitle: Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26913Best OA location URL: https://ri.conicet.gov.ar/bitstream/11336/40514/5/CONICET_Digital_Nro.82df6a72-6ca0-4e97-82ab-71e013c4c8bf_s.pdfCitation Count: 148
-
OPENTitle: Multi-modal and targeted imaging improves automated mid-brain segmentationJournal Name: SPIE ProceedingsPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2254428Best OA location URL: https://europepmc.org/articles/pmc5544135?pdf=renderCitation Count: 2
-
OPENTitle: Multi-scale hippocampal parcellation improves atlas-based segmentation accuracyJournal Name: SPIE ProceedingsPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2254425Best OA location URL: https://europepmc.org/articles/pmc5544133?pdf=renderCitation Count: 10
-
OPENTitle: Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysisJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 3Start Page: 212End Page: 216Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.381Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.381Citation Count: 25
-
OPENTitle: Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's DiseaseJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 6Start Page: 578End Page: 585Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205014666170203093219Best OA location URL: https://europepmc.org/articles/pmc6091859?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 12
-
RESTRICTEDTitle: Post translational modification of ParkinJournal Name: Biology DirectPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13062-017-0176-3Best OA location URL: https://biologydirect.biomedcentral.com/track/pdf/10.1186/s13062-017-0176-3Citation Count: 43
- Classification of brain disease in magnetic resonance images using two-stage local feature fusion2017OPENTitle: Classification of brain disease in magnetic resonance images using two-stage local feature fusionJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 2Start Page: e0171749End Page: e0171749Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0171749Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171749&type=printableCitation Count: 13
-
OPENTitle: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0051-5Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0051-5Citation Count: 80
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned2017RESTRICTEDTitle: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learnedJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 37Issue #:Start Page: 101End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003Citation Count: 31
- Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice2017OPENTitle: Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system miceJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0158-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0158-zCitation Count: 51
- Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression2017OPENTitle: Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP ExpressionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 120Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/54981Best OA location URL: https://europepmc.org/articles/pmc5409190?pdf=renderCitation Count: 7
- AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models2017RESTRICTEDTitle: AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease ModelsJournal Name: GenesPublisher: MDPI AGVol: 8Issue #: 2Start Page: 63End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes8020063Best OA location URL: https://www.mdpi.com/2073-4425/8/2/63/pdf?version=1486965246Citation Count: 45
-
RESTRICTEDTitle: The LRRK2–macroautophagy axis and its relevance to Parkinson's diseaseJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 45Issue #: 1Start Page: 155End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bst20160265Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/45/1/155/432837/bst-2016-0265.pdfCitation Count: 61
-
OPENTitle: Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson’s diseaseJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-017-0285-zBest OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-017-0285-zCitation Count: 43
- Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study2017OPENTitle: Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological StudyJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 4Start Page: 322End Page: 331Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000017Best OA location URL: https://europepmc.org/articles/pmc5729910?pdf=renderCitation Count: 18
- Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic losses2017OPENTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://europepmc.org/articles/pmc5386784?pdf=renderCitation Count: 44
-
OPENTitle: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant PathwaysJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 16Issue #: 4Start Page: 581End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1074/mcp.m116.061440Best OA location URL: https://www.mcponline.org/content/mcprot/16/4/581.full.pdfCitation Count: 57
-
OPENTitle: Probabilistic conversion of neurosurgical DBS electrode coordinates into MNI spaceJournal Name: NeuroImagePublisher: Elsevier BVVol: 150Issue #:Start Page: 395End Page: 404Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.004Best OA location URL: https://europepmc.org/articles/pmc6050588?pdf=renderCitation Count: 138
- LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila2017OPENTitle: LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in DrosophilaJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 26Issue #: 7Start Page: 1247End Page: 1257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddx030Best OA location URL: https://academic.oup.com/hmg/article-pdf/26/7/1247/25421311/ddx030.pdfCitation Count: 20
- AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease2017OPENTitle: AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0416-xBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0416-xCitation Count: 119